<p>In June 1987, neurobiologists, immunologists, molecular biologists, virologists and neurologists from several countries met in Vancouver to discuss recent advances of relevance to multiple sclerosis. The symposium was a part of the 22nd Canadian Congress of Neurological Sciences meeting and was s
Multiple Sclerosis and Demyelinating Diseases
β Scribed by Mark Freedman MD
- Publisher
- LWW
- Year
- 2005
- Tongue
- English
- Leaves
- 391
- Series
- Advances in Neurology
- Edition
- 1
- Category
- Library
No coin nor oath required. For personal study only.
β¦ Synopsis
This volume in the distinguished Advances in Neurology series focuses on multiple sclerosis and related demyelinating diseases. An international group of experts examines recent developments in diagnosis, treatment, and other aspects of clinical management. The latest cutting-edge research on the causes and mechanisms of these diseases is also discussed.
Coverage includes detailed discussions on new diagnostic methods and the role of neuroimaging in diagnosis. Chapters present evidence-based treatment protocols and review current clinical testing of new therapies.
β¦ Subjects
Multiple Sclerosis;Diseases & Physical Ailments;Health, Fitness & Dieting;Neurology;Alzheimerβs Disease;Headache;Neuroscience;Internal Medicine;Medicine;Diseases;AIDS & HIV;Brain;Cancer;Cardiovascular;Communicable Diseases;Diabetes;Digestive Organs;Extremities;Psoriasis;Viral;Pathology;Internal Medicine;Medicine
π SIMILAR VOLUMES
<P>There is a need for a paradigm shift in our thinking about the pathogenesis of multiple sclerosis.</P> <P>Challenging Charcot s hypothesis that inflammatory response is the primary contributor to demyelination, Dr. Rodriguez and colleagues take a fresh, bold look at the causes and possible
<p><P>"There is a need for a paradigm shift in our thinking about the pathogenesis of multiple sclerosis."</P><P></P><P>Challenging Charcotβs hypothesis that inflammatory response is the primary contributor to demyelination, Dr. Rodriguez and colleagues take a fresh, bold look at the causes and poss
Differentiating multiple sclerosis (MS) from alternative demyelinating diseases of the central nervous system and systemic medical conditions that mimic MS is challenging. A simple three-step approach is used in this text to guide readers through clinical cases to define MS and rule out competing ca
<p><p><b><i>Myelin Repair and Neuroprotection in Multiple Sclerosis</i></b> presents an up-date on the translational potential of promoting remyelination in multiple sclerosis (MS). A number of research frontiers still exist in this challenging disease. The cause remains elusive, preventing breakthr
<p>A satellite symposium entitled "Myelination and Demyelination: Recent Chemical Advances" was held in Helsinki from August 29 to 31, 1977, after the Sixth International Meeting of the International Society for Neurochemistry (ISN) in Copenhagen. Myelin is a nervous tissue structure that is most su